| P50 | author | Carol A Lange | Q101563783 |
| P2093 | author name string | Christy R Hagan | |
| P2860 | cites work | A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk | Q24535819 |
| | Genetic variation in the progesterone receptor gene and ovarian cancer risk | Q24540482 |
| | Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B | Q24556548 |
| | Comprehensive molecular portraits of human breast tumours | Q24630844 |
| | Progesterone receptors--animal models and cell signalling in breast cancer. Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer | Q24800251 |
| | Antiprogestins in breast cancer treatment: are we ready? | Q27693318 |
| | Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters | Q28116725 |
| | Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes | Q28306753 |
| | MAP kinase phosphatase 3 (MKP3) interacts with and is phosphorylated by protein kinase CK2alpha | Q28593793 |
| | Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells | Q28771752 |
| | Nuclear receptor coregulators: cellular and molecular biology | Q29547588 |
| | One-thousand-and-one substrates of protein kinase CK2? | Q29615345 |
| | The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle | Q30159541 |
| | Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases | Q30167936 |
| | Menopausal hormone therapy and breast cancer | Q30456820 |
| | Risk of breast cancer with progestins: critical assessment of current data | Q30885896 |
| | Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells | Q33295020 |
| | Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors | Q33315228 |
| | Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models | Q33428469 |
| | Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells | Q33496645 |
| | Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator | Q33552193 |
| | The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention | Q33699615 |
| | Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis | Q38456582 |
| | Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells. | Q39588977 |
| | Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer | Q39819693 |
| | Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist | Q40202330 |
| | Phosphorylation and progesterone receptor function. | Q40455187 |
| | Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. | Q40486142 |
| | Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). | Q41084288 |
| | Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody | Q41713285 |
| | Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression | Q42445773 |
| | Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP/p300. | Q42454022 |
| | Progesterone induces adult mammary stem cell expansion | Q42471079 |
| | Steroid hormone receptor status of mouse mammary stem cells | Q42498451 |
| | Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. | Q42506249 |
| | Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters | Q42804329 |
| | Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors. | Q44294752 |
| | Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2. | Q44847818 |
| | Cross-talk between growth factor and progesterone receptor signaling pathways: implications for breast cancer cell growth | Q45248777 |
| | Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer | Q46120245 |
| | Breast cancer risk in postmenopausal women using estradiol-progestogen therapy | Q46185602 |
| | Progesterone/RANKL is a major regulatory axis in the human breast. | Q51042996 |
| | Breast cancer and hormone-replacement therapy: the Million Women Study | Q56863703 |
| | Association of the Progesterone Receptor Gene with Breast Cancer Risk: A Single-Nucleotide Polymorphism Tagging Approach | Q57306187 |
| | Colocalization of Progesterone Receptors A and B by Dual Immunofluorescent Histochemistry in Human Endometrium during the Menstrual Cycle1 | Q60662131 |
| | The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial | Q68194017 |
| | Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study | Q71692742 |
| | Characterization of progesterone receptor A and B expression in human breast cancer | Q71804872 |
| | Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast | Q73276429 |
| | A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions | Q74181062 |
| | Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family | Q78036268 |
| | Progesterone receptor isoforms in normal and malignant breast | Q81424333 |
| | Ulipristal acetate does not impact human normal breast tissue | Q84476268 |
| | Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. | Q33733718 |
| | Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer | Q33871076 |
| | Role of phosphorylation in progesterone receptor signaling and specificity | Q34029956 |
| | Pioneer factors: directing transcriptional regulators within the chromatin environment | Q34212702 |
| | Breast cancer and hormone-replacement therapy in the Million Women Study | Q34223870 |
| | Protein kinase CK2 signal in neoplasia | Q34238490 |
| | Pioneer factors in hormone-dependent cancers | Q34272580 |
| | Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. | Q34300189 |
| | Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression | Q34304234 |
| | Identification of phosphorylation sites unique to the B form of human progesterone receptor. In vitro phosphorylation by casein kinase II. | Q34327103 |
| | Measurement of steroid hormone receptors in breast cancer patients on tamoxifen | Q34345668 |
| | Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort | Q34552706 |
| | Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome | Q34999960 |
| | ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells | Q35096710 |
| | MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association | Q35207726 |
| | Structural and functional analysis of domains of the progesterone receptor | Q35624126 |
| | Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells | Q35642132 |
| | Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes | Q35910912 |
| | Antiprogestins, a new form of endocrine therapy for human breast cancer | Q36024326 |
| | Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells | Q36367151 |
| | Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts. | Q36558052 |
| | Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cycli | Q36700634 |
| | Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer | Q36782597 |
| | Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis | Q36938367 |
| | A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells | Q37236792 |
| | Protein kinase CK2 in human diseases. | Q37239690 |
| | Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells | Q37249108 |
| | The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. | Q37384523 |
| | Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women | Q37480990 |
| | A 2009 update on the treatment of patients with hormone receptor-positive breast cancer | Q37533811 |
| | Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients | Q37639114 |
| | Acquired endocrine resistance in breast cancer: implications for tumour metastasis | Q37825181 |
| | Progesterone signalling in breast cancer: a neglected hormone coming into the limelight | Q38109029 |
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | progesterone | Q26963 |
| | breast cancer | Q128581 |
| | breast neoplasm | Q23929670 |
| | progesterone receptor | Q24783718 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 32 | |
| P577 | publication date | 2014-02-20 | |
| P1433 | published in | BMC Medicine | Q4835947 |
| P1476 | title | Molecular determinants of context-dependent progesterone receptor action in breast cancer | |
| P478 | volume | 12 | |